Patent · US Active

Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-benzodioxan

US7488751B2 · kind B2 · utility

0Cited by
4References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 10, 2006
Grant dateFeb 10, 2009
Priority date
Expiry dateMay 18, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of the Formula I:are useful for the treatment of depression (including but not limited to major depressive disorder, childhood depression and dysthymia), anxiety, panic disorder, post-traumatic stress disorder, premenstrual dysphoric disorder (also known as pre-menstrual syndrome), attention deficit disorder (with and without hyperactivity), obsessive compulsive disorder, social anxiety disorder, generalized anxiety disorder, obesity, eating disorders such as anorexia nervosa and bulimia nervosa, vasomotor flushing, cocaine and alcohol addiction, sexual dysfunction and related illnesses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.